New nerve block could ease pain after Open-Heart surgery
NCT ID NCT07232992
First seen Nov 18, 2025 · Last updated Jun 23, 2026 · Updated 28 times
Summary
This study tested a new type of nerve block called the serratus posterior superior intercostal plane block (SPSIPB) for pain after open-heart surgery. 70 adults undergoing elective open-heart surgery received either the SPSIPB or standard blocks. Researchers measured opioid use and pain scores over 24 hours to see if the new block offers better pain relief and recovery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPEN-HEART SURGERY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Bursa City Hospital
Bursa, Turkey (Türkiye)
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
bupivacaine
What this could lead to
If it works, this could offer a better way to manage pain after open-heart surgery, reducing opioid use and improving recovery.
What could go wrong
This is a small, early-stage trial with only 70 participants, so results may not apply to everyone. The block may not provide better pain relief than current methods.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.